APP and amyloidosis: IL-33 can reverse the synaptic plasticity damage and memory deficits in APP/PS1 mice, and its mechanism may be to promote the differentiation of microglia into an anti-inflammatory phenotype and reduce soluble Aβ levels and amyloid plaque deposition [30].